TALPHERA, INC. Available-for-sale Securities, Gross Realized Losses
TALPHERA, INC. (TLPH) reported Available-for-sale Securities, Gross Realized Losses of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-13.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses · last filed 2015-03-13
- TALPHERA, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-12-31 was $0.00.
- TALPHERA, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-09-30 was $0.00.
- TALPHERA, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-06-30 was $0.00.
- TALPHERA, INC. available-for-sale securities, gross realized losses for the quarter ending 2014-03-31 was $0.00.
- TALPHERA, INC. available-for-sale securities, gross realized losses for fiscal 2014 was $0.00.
- TALPHERA, INC. available-for-sale securities, gross realized losses for fiscal 2013 was $0.00.
- TALPHERA, INC. available-for-sale securities, gross realized losses for fiscal 2012 was $0.00.
- TALPHERA, INC. available-for-sale securities, gross realized losses for fiscal 2011 was $0.00.
| Period end | Available-for-sale Securities, Gross Realized Losses 3 month | Available-for-sale Securities, Gross Realized Losses 6 month | Available-for-sale Securities, Gross Realized Losses 9 month | Available-for-sale Securities, Gross Realized Losses 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $0.00 derived: sum of 2 quarters · filed 2015-03-13 | $0.00 derived: sum of 3 quarters · filed 2015-03-13 | $0.00 10-K · filed 2015-03-13 |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2015-03-13 |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-13 | $0.00 derived: sum of 4 quarters · filed 2015-03-13 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-08 | $0.00 derived: sum of 2 quarters · filed 2015-03-13 | $0.00 derived: sum of 3 quarters · filed 2015-03-13 | $0.00 derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $0.00 derived: sum of 2 quarters · filed 2015-03-13 | $0.00 derived: sum of 3 quarters · filed 2015-03-13 | $0.00 10-K · filed 2015-03-13 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2014-08-11 | $0.00 derived: sum of 4 quarters · filed 2014-08-11 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-05-08 | $0.00 derived: sum of 3 quarters · filed 2014-05-08 | $0.00 derived: sum of 4 quarters · filed 2014-05-08 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $0.00 derived: sum of 2 quarters · filed 2014-03-17 | $0.00 derived: sum of 3 quarters · filed 2014-03-17 | $0.00 10-K · filed 2014-03-17 |
| 2012-09-30 | $0.00 10-Q · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $0.00 10-Q · filed 2013-11-05 | |
| 2012-06-30 | $0.00 10-Q · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | ||
| 2011-12-31 | $0.00 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |